Topical anionic salicylate for disorders of the skin

Details Topical anionic salicylate for disorders of the skin Topical anionic salicylate for disorders of the skin

1998-08-19

2000-09-19

Richter, Johann

Drug, bio-affecting and body treating compositions

Live hair or scalp treating compositions

Polymer containing

424 7011, 424401, 424 59, 514887, 514844, 514845, 514846, 514847, A61K 706, A61K 700, A61K 742, A61K 600

Patent

active

06120756&

ABSTRACT:
A method of treating or preventing a skin disorder caused by at least one of excessive sebum production and abnormal keratinocyte proliferation, the method comprising topically administering to a region of the skin of a human affected by or susceptible to a skin disorder caused by at least one of excessive sebum and abnormal keratinocyte proliferation, a composition comprising anionic salicylate in an amount effective to reduce or stop the occurrence or delay the occurrence of at least one of the excessive sebum production and abnormal keratinocyte proliferation.

REFERENCES:
patent: 3790671 (1974-02-01), Sim
patent: 4126681 (1978-11-01), Reller
patent: 4136165 (1979-01-01), Moller et al.
patent: 4219548 (1980-08-01), Reller
patent: 4299826 (1981-11-01), Luedders
patent: 4440777 (1984-04-01), Zupan
patent: 4514385 (1985-04-01), Damani et al.
patent: 4665063 (1987-05-01), Bar-Shalom
patent: 4671956 (1987-06-01), Bouillon et al.
patent: 4891227 (1990-01-01), Thaman
patent: 4933330 (1990-06-01), Jorgensen et al.
patent: 5019567 (1991-05-01), Phillippe et al.
patent: 5262407 (1993-11-01), Leveque et al.
patent: 5559098 (1996-09-01), Wohlrab et al.
patent: 5616572 (1997-04-01), Blank
patent: 5652266 (1997-07-01), Bobier-Rival et al.
patent: 5723109 (1998-03-01), Causse et al.
patent: 5728732 (1998-03-01), Corey et al.
patent: 5741497 (1998-04-01), Guerrero et al.
patent: 5773015 (1998-06-01), Bajor et al.
File registry, salicylate structure and comparative names, ACS,RN 63-36-5.
Olin et al., Facts and Comparisons, St. Louis, MO: JB Lippincott, p. 62, Apr. 1986.
Lehninger, A.L., Biochemistry, Worth Publishers, Inc., New York, NY, p. 584 (1982).
Williams, M.L. et al., "Exogenous origins of n-alkanes in pathologic scale", Archives of Dermatology, 128(8):1065-71 (1992).
Cinical Toxicology of Commercial Products, Gosselin, R.E., Smith, R.P., Hodge, H.C., Williams & Wilkins, Baltimore, MD, p. II-177 (1984).
Reed, G.A., Ryan, M.J., "Peroxyl radical-dependent epoxidation of cyclopenteno[ac,d]pyrene", Carcinogenesis, 11(10):1825-9 (1990) (Abstract Only).
Wistuba, D. et al., "Cytochrome P-450 catalyzed asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes: species dependence and effect of enzyme induction on enantioselective oxirane formation", Chirality, 1(2):127-36 (1989) (Abstract Only).
Verschueren, K., Handbook of Environmental Data on Organic Chemicals, Van Nostrand, pp. 36, 48, 900 and 1484 (1996).
Lin, J.K., "Nitrosamines as potential environmental carcinogens in man", Clinical biochemistry, 23(1):67-71 (1990) (Abstract Only).
Farivar, R.S., Brecher, P., Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts, Journal of Biological Chemistry, 271(49):31585-31592 (1996).
Schwenger, P. et al., "Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation", Proc. Natl. Acad. Sci. USA, 94:2869-73 (1997).
Elder et al., "Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines", Cancer Research, 56:2273-6 (1996).
Khan, K.A., "Comparative genotoxicity of six salicylic acid derivatives in bone marrow cells of mice", Mutation Research, 370(1):1-9 (1996).
Goodman and Gilman, "The Pharmacological Basis of Therapeutics", Hardman, J.G. and Limbird, L.E. (Eds), Analgesic-Antipyretic and Antiinflammatory Agents, McGraw-Hill, New York, NY, p. 628 (1996).
Williams, M.L., Elias, P.M., "Elevated n-alkanes in congenital ichthyosiform erthroderma. Phenotypic differentiation of two types of autosomal recessive ichthyosis", Journal of Clinical Investigation, 74(1):296-300 (1984).
Brown, B.E. et al., "Stratum corneum lipid abnormalities in ichthyosis. Detection by a new lipid microanalytical method", Archives of Dermatology, 120(2):204-9 (1984).
Sagone, A.L., Husney, R.M., "Oxidation of salicylates by stimulated granulocytes:evidence that these drugs act as free radical scavengers in biological systems", Journal of Immunology, 138(7):2177-83 (1987).
Maskos, et al., "The hydroxylation of the salicylate anion (italics added) by a Fenton reaction and T-radiolysis: a consideration of the respective mechanisms", Free Radical Biology and Medicine, 8(2):153-62 (1990).
Fischer-Nielsen, A., et al., "Radiation-induced formation of 8-hydroxy-2-deoxyguanosine and its prevention by scavengers", Carcinogenesis, 15(8):1609-12 (1994) (Abstract Only).
Dong, Z., "Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-2-luciferase transgenic mice", Journal of Biological Chemistry, 272(42):26325-31 (1997).
Peter M. Elias et al., "Lipids and the Epidermal Water Barrier: Metabolism, Regulation, and Pathophysiology," Seminars in Dermatology, 11(2):176-182 (Jun. 1992).
Mary L. Williams, "Epidermal Lipids and Saling Diseases of the Skin," Seminars in Dermatology, 11(2):169-175 (Jun. 1992).
Gerald Weissmann, "Aspirin," Scientific American, pp. 84-90 (Jan. 1991).
Product Info. Sheet of Very Europe S.P.A., Genova, Italy, "BTN.RTM.," 7 pages (1991).
"Tridecanol (mixtures of isomers)," Chemical Safety Sheets, Kluwer Academic Publishers, Dordrecht, Netherlands, p. 882 (1991).
Single Sheet re. 1-dodecanol, Handbook of Environmental Data on Organic Chemicals, Verschueren, Van Nostrand Reinhold, New York, NY (1996).
Single Sheet re. 1-octanol, Handbook of Environmental Data on Organic Chemicals, Verschueren, Van Nostrand Reinhold, New York, NY (1996).
P.E. Kolattukudy, "Biosynthesis of Surface Lipids," Science, 159:498-505 (1968).
Paige E. Tolbert, "Oils and cancer," Cancer Causes and Control, 8:386-405 (1997).
English Abstract Only13 J.K. Lin, "Nitrosamines as potential environmental carcinogens in man," Source: Clinical Biochemistry, 23(1):67-71 (Feb. 1990).
The Merck Index, Eleventh Edition, publ. Merck & Co., Inc., Rahway, NJ, pp. 1367-1368, p. 893 (1989).
Ernst Zander, M.D., et al., "Treatment of Acne Vulgaris with Salicylic Acid Pads," Clinical therapeutics, 142(2):247-253 (1992).
Peter Goldman, "The Inhibition of the Biosynthesis of Long-Chain Fatty Acids by Salicylate and Nicotinate," Biochemical Pharmacology, 16:47-52 (1967).
A.N. Klimov et al., "The effect of salicylate on the activity of a cetyl-CoA carboxylase in rat liver," Biochemical Pharmacology, 26:898-899 Pergamon Press, Printed in Great Britain (1979).
Usha Dular et al., "Effect of Salicylates on Acetyl Coenzyme A Carboxylase," Biochemical Pharmacology, 28:715-718, Pergamon Press Ltd., Printed in Great Britain (1979).
M.J.H. Smith et al., "Salicylate and enzymes," J. Pharm. Pharmac., 23:729-744 (1971).
P.D. Dawkins et al., "The mechanism of the inhibition of dehydrogenases by salicylate," J. Pharm. Pharmac., 19:355-366 (1967).
James J. Leyden, M.D., "Review Article--Drug Therapy--Therapy for Acne Vulgaris," The New England Journal of Medicine, Alastair J.J. Wood, M.D., Ed., pp. 1156-1162 (Apr. 17, 1997).

Affiliated with

Also associated with

Rating

Topical anionic salicylate for disorders of the skin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical anionic salicylate for disorders of the skin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anionic salicylate for disorders of the skin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1069346